- Eupraxia Pharmaceuticals experienced a significant surge in trading volume, with 3,055,170 shares traded, representing a 996% increase from the previous session.
- The company's stock last traded at $8.01, reflecting a 6.7% increase alongside recent analyst rating adjustments and a market capitalization of $520.49 million.
- Several major institutional investors, including the Royal Bank of Canada and JPMorgan Chase & Co., recently adjusted their holdings in the company.